E
Pharmadrug Inc. PHRX
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -203.00K -246.30K -545.10K -9.64M -9.73M
Total Depreciation and Amortization 36.10K 36.20K 36.70K 47.00K 37.80K
Total Amortization of Deferred Charges -- -- -- 0.00 4.40K
Total Other Non-Cash Items 107.40K 161.00K 171.70K 9.01M 8.99M
Change in Net Operating Assets -9.30K -116.70K -222.10K -188.40K -182.40K
Cash from Operations -69.00K -166.00K -558.90K -773.60K -885.00K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- 545.10K 545.10K
Divestitures -- -- -- -- --
Other Investing Activities -8.60K -8.60K -8.60K -200.00 5.80K
Cash from Investing -8.60K -8.60K -8.60K 544.80K 550.80K
Total Debt Issued -- -- -- 0.00 0.00
Total Debt Repaid -- -- -- 0.00 0.00
Issuance of Common Stock -- 0.00 326.00K 326.00K 326.00K
Repurchase of Common Stock -91.60K -91.60K -91.60K -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 87.20K 87.20K 87.20K -51.10K 248.90K
Cash from Financing -3.20K -3.20K 238.60K 204.20K 427.90K
Foreign Exchange rate Adjustments -1.70K -1.70K -1.70K 600.00 1.30K
Miscellaneous Cash Flow Adjustments -- -- -- 0.00 0.00
Net Change in Cash -82.40K -179.40K -330.50K -24.00K 95.00K